Nomir's antifungal laser system closer to US market
This article was originally published in Clinica
Executive Summary
Noveon, a laser device developed by Nomir Medical Technologies, represents "a possible novel and safe topical phototherapy" for onychomycosis, a trial has concluded.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.